China Pharma Holdings Inc. (CPHI)
NYSE · Healthcare
China Pharma Holdings Inc. Long Term Debt 2010–2025
China Pharma Holdings Inc. annual/quarterly long term debt history from 2017 to 2020. Long term debt refers to financial obligations that are due more than one year in the future.
- China Pharma Holdings Inc. long term debt for the quarter ending December 31, 2020 were 5.2M, a 21.88% increase year-over-year.
- China Pharma Holdings Inc. long term debt for 2020 were 5.2M, a 21.88% increase from 2019.
- China Pharma Holdings Inc. long term debt for 2019 were 4.3M, a 34.29% decrease from 2018.
- China Pharma Holdings Inc. long term debt for 2018 were 6.5M, a 29.04% decrease from 2017.
- China Pharma Holdings Inc. long term debt for 2017 were 9.2M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| China Pharma Holdings Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2020 | $5 |
| 2019 | $4 |
| 2018 | $7 |
| 2017 | $9 |
| China Pharma Holdings Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2020-12-31 | $5 |
| 2019-12-31 | $4 |
| 2018-12-31 | $7 |
| 2017-12-31 | $9 |
China Pharma Holdings Inc. Long Term Debt — FAQ
China Pharma Holdings Inc. (CPHI) long term debt over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CPHI's long term debt history?
The chart and table above show China Pharma Holdings Inc.'s long term debt by year and by quarter, including the growth rate.